These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12493335)

  • 1. Living with a variable disease.
    Partridge MR
    Pulm Pharmacol Ther; 2002; 15(6):491-6. PubMed ID: 12493335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The patient's perspective: adherence or non-adherence to asthma controller therapy?
    Ulrik CS; Backer V; Søes-Petersen U; Lange P; Harving H; Plaschke PP
    J Asthma; 2006 Nov; 43(9):701-4. PubMed ID: 17092852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences.
    Apter AJ; Reisine ST; Affleck G; Barrows E; ZuWallack RL
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1810-7. PubMed ID: 9620910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?
    Beasley R; Weatherall M; Shirtcliffe P; Hancox R; Reddel HK
    J Allergy Clin Immunol; 2014 Jan; 133(1):39-41. PubMed ID: 24369798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.
    Bijl-Hofland ID; Cloosterman SG; Folgering HT; van den Elshout FJ; van Weel C; van Schayck CP
    Am J Respir Crit Care Med; 2001 Sep; 164(5):764-9. PubMed ID: 11549530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
    Perrin K; Williams M; Wijesinghe M; James K; Weatherall M; Beasley R
    J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bronchial asthma: a comparison of the doctor's assessment and the patient's opinion].
    Gillissen A; Lecheler J
    Dtsch Med Wochenschr; 2004 Mar; 129(10):484-9. PubMed ID: 14986236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma control: importance of compliance and inhaler technique assessments.
    Baddar S; Jayakrishnan B; Al-Rawas OA
    J Asthma; 2014 May; 51(4):429-34. PubMed ID: 24304046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence.
    Onyirimba F; Apter A; Reisine S; Litt M; McCusker C; Connors M; ZuWallack R
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):411-5. PubMed ID: 12722963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficult asthma: people's perspectives on taking corticosteroid therapy.
    Gamble J; Fitzsimons D; Lynes D; Heaney LG
    J Clin Nurs; 2007 Mar; 16(3A):59-67. PubMed ID: 17518870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adherence to therapy in bronchial asthma].
    Gillissen A; Büsch K; Juergens U
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1281-6. PubMed ID: 17541872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key barriers to optimal management of adult asthma in Australia: physician and patient perspectives.
    Heiner MM
    Curr Med Res Opin; 2007 Aug; 23(8):1799-807. PubMed ID: 17597555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmeterol: a long-acting beta 2-agonist.
    D'Alonzo GE; Tolep K
    J Am Osteopath Assoc; 1998 Apr; 98(4):216-8, 221-31. PubMed ID: 9594486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.
    National Asthma Education and Prevention Program
    J Allergy Clin Immunol; 2007 Nov; 120(5 Suppl):S94-138. PubMed ID: 17983880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing asthma in the real world.
    Gillissen A
    Int J Clin Pract; 2004 Jun; 58(6):592-603. PubMed ID: 15311560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving patient compliance with asthma therapy.
    Chapman KR; Walker L; Cluley S; Fabbri L
    Respir Med; 2000 Jan; 94(1):2-9. PubMed ID: 10714473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.